Fidelity Investments
QGENF

Fidelity Investments’s QIAGEN NV QGENF Stock Holding History

Fidelity Investments’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-165,800
Closed -$4.65M – 2791
2016
Q4 		$4.65M Sell
165,800
-473,415
-74% -$13.3M ﹤0.01% 2196
2016
Q3 		$17.5M Buy
+639,215
New +$17.5M ﹤0.01% 1738
2015
Q2 		– Sell
-32,158
Closed -$810K – 2903
2015
Q1 		$810K Sell
32,158
-1,995
-6% -$50.3K ﹤0.01% 2546
2014
Q4 		$801K Hold
34,153
– – ﹤0.01% 2576
2014
Q3 		$778K Hold
34,153
– – ﹤0.01% 2568
2014
Q2 		$835K Sell
34,153
-320,097
-90% -$7.83M ﹤0.01% 2534
2014
Q1 		$7.47M Sell
354,250
-567,500
-62% -$12M ﹤0.01% 2110
2013
Q4 		$21.9M Buy
921,750
+237,600
+35% +$5.66M ﹤0.01% 1672
2013
Q3 		$14.6M Buy
684,150
+21,050
+3% +$450K ﹤0.01% 1805
2013
Q2 		$13.2M Buy
+663,100
New +$13.2M ﹤0.01% 1835

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Fidelity Investments's QGENF Position: Q1 2017 in Review

Fidelity Investments sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 165,800 shares — an estimated $4.65M sold.

Fidelity Investments first reported a position in QGENF in Q2 2013 and held it in 10 quarters. The position peaked at $21.9M in Q4 2013. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Fidelity Investments reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Fidelity Investments sold 165,800 QIAGEN NV shares in Q1 2017, an estimated $4.65M.
  • Fidelity Investments first reported a position in QIAGEN NV in Q2 2013 and held it in 10 quarters.
  • Fidelity Investments's QIAGEN NV position peaked at $21.9M in Q4 2013.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Fidelity Investments's 13F filing for Q1 2017, filed 11 May 2017.